Collegium Pharmaceutical (COLL) Work In Process (2016 - 2025)

Collegium Pharmaceutical's Work In Process history runs 10 years deep, the most recent figure standing at $11.6 million for Q3 2025.

• On a quarterly basis, Work In Process fell 33.12% year-over-year to $11.6 million in Q3 2025; TTM through Sep 2025 was $11.6 million, a 33.12% decrease from a year earlier, with the FY2024 full-year figure at $13.2 million, up 95.3% from the prior year.
• Work In Process eased to $11.6 million in Q3 2025 per COLL's latest filing, from $12.1 million in the prior quarter.
• Across five years, Work In Process topped out at $46.4 million in Q2 2022 and bottomed at $802000.0 in Q1 2021.
• The 5-year median for Work In Process is $11.6 million (2025), against an average of $14.1 million.
• Across the five-year window, Work In Process surged 4252.49% in 2022 and sank 83.92% in 2023, its largest moves.
• Year by year, Work In Process stood at $1.0 million in 2021, then soared by 2350.05% to $24.7 million in 2022, then plunged by 72.68% to $6.7 million in 2023, then soared by 95.3% to $13.2 million in 2024, then declined by 11.65% to $11.6 million in 2025.
• Per Business Quant, the three latest COLL Work In Process figures stand at $11.6 million (Q3 2025), $12.1 million (Q2 2025), and $11.6 million (Q1 2025).